Cogthera, LLC
Publicly observedBrookeville, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Brookeville | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Cogthera, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | W4P2GVQJL4D1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 May 2021Publicly observed
NIH SBIR/STTR award: Title: Developing a novel drug for neurobehavioral deficits in FASD
USD 1,008,965.00 · National Institute on Alcohol Abuse and Alcoholism · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2021Publicly observed
NIH SBIR/STTR award: Title: Developing a novel drug for neurobehavioral deficits in FASD
USD 1,077,312.00 · National Institute on Alcohol Abuse and Alcoholism · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.